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Introduction
The genus Vibrio is one of the six members of the Vibrionaceae family and includes ten species pathogenic to humans. Probably the most well-known species is Vibrio cholerae. Currently, there are over 130 known serogroups based on the presence of somatic O antigens [1, 2] . Serogroup O1 and to a lesser extent O139, is notorious for cholera outbreaks of dysenteric diarrhoea due to toxin production i.e. cholera toxin: ctx and toxin co-regulated pilus subunit A: tcpA. Infections are mostly confined to the gastro-intestinal tract [1] .
In contrast, V. cholerae non-O1 (VCNO) i.e. all serogroups except O1, rarely causes cholera-like outbreaks in form of mild diarrhoea due to toxin-producing VCNO strains but can cause severe extra intestinal infections such as wound infections and bacteraemia [3, 4] . Cases of VCNO bacteraemia are reported in various countries and known risk factors are liver disease/cirrhosis and immunosuppression/immunocompromising conditions [1, 3, 4] . Sources of infection include seafood and contaminated water [5] . In the Netherlands, VCNO has indeed been isolated from recreational surface water (fresh and brackish) and sporadically from livestock [5, 6] . In contrast, a Dutch study from 2010 showed that none of the examined shellfish tested positive for V. cholerae [7] .
V. cholerae is a facultative anaerobic Gram-negative curved or comma-shaped motile bacillus. It can be isolated from blood by using standard culture media such as blood agar [1] . Biochemical properties of this organism include catalase positivity, oxidase positivity, sucrose fermentation and susceptibility for the vibriostatic compound O129. Identification methods are various and include: matrix assisted laser desorption ionization-time-of-flight (MALDI-TOF) analyser (MALDI-TOF, Bruker corporation), VITEK systems (BioMerieux corporation) and polymerase chain reaction (PCR) for 16S and target genes like toxR, ompW and sodB. The non-O1 serogroup can be distinguished from other serotypes by a lack of agglutination with O1-Ogawa and O1-Inaba antigen [1] .
In 2013, a patient with a fulminant VCNO sepsis and extensive bullae on the lower extremities was admitted to the Leiden University Medical Centre (LUMC). When searching for literature on VCNO sepsis to help determine the source of infection and the optimal treatment strategy, we realised that the available literature appeared to be limited to case reports and small case series. In order to provide evidence for clinicians and public health experts about VCNO bacteraemia we report on a series of three cases and summarise the available literature on VCNO bacteraemia.
Methods

Clinical case reports
During the presentation of the LUMC case at the annual Dutch convention for medical microbiology, we inquired if any of the attending medical microbiologists was aware of additional cases of VCNO sepsis detected in the Netherlands. There is no mandatory notification for VCNO isolates in the Netherlands and VCNO sepsis is rare. Thus, retrieving VCNO sepsis cases detected in the Netherlands in another fashion was not feasible.
Literature review
In collaboration with an experienced information specialist of the LUMC library, we formulated a search strategy including synonyms for 'V. cholera non-O1' and 'bacteraemia' and applied it to PubMed, Medline, Web of Science and Embase databases ( Table 1) . Articles published before 15 September 2014 were included. Additional articles were identified by checking the references of relevant articles and duplicates were excluded.
Retrieved articles were screened based on title and abstract, and exclusion criteria were: Vibrio spp. other than V. cholerae non-O1, article not available through the journal's archive/the main author i.e. unanswered email after three months, in vitro data only, environmental samples only, no bacteraemia, no humans, limited clinical data, languages other than English or Dutch. No date limits were applied.
Data of individual case reports were merged and discussed as one patient group. Articles discussing case series were reported separately to prevent overlapping data. Extracted data included: patient demographics, medical history, risk factors i.e. exposure, clinical presentation, laboratory identification method, antimicrobial susceptibility, toxin production, samples cultured aside from blood, treatment and clinical outcome. If antimicrobial resistance was reported for 10 cases or more, they were reported in this article.
Results
Clinical case reports
In addition to the LUMC case, two additional cases were detected in different Dutch medical centres in 2006 and 2007. A relevant selection of the available data per case is presented; none of the isolates were tested for toxin production. All cases were men and above 50 years of age, with infections during the summer season.
Case 1
Case 1 was a man in his 50s, with a medical history of tuberculosis, chronic obstructive pulmonary disease, depression, marihuana and excessive alcohol use. One day prior to admission, he felt lethargic and developed a painful discoloration on his right ankle. Three days before hospital admission he had walked barefoot along the Dutch shoreline and ate a ready-made tuna salad. Upon admission at the emergency department (ED) he was hypothermic (34.1°C, norm: 36.5to37.5), blood pressure was 112/70 mmHg (norm: 120/80), heart rate 115 per minute (norm: 60 to 100), O2 saturation was 90% without additional O2 (norm: 93 to 100). While in the ED he developed circulatory failure.
There were no abnormalities on chest auscultation. Inspection of the lower extremities showed oedema, blue discoloration and large bullae on both lower extremities. The chest X-ray showed patchy bilateral abnormalities of which the differential diagnosis comprised acute respiratory distress syndrome, bilateral pneumonia and pre-existing abnormalities after pulmonary tuberculosis.
Analysis of arterial blood at admission showed severe metabolic acidosis with respiratory compensation: pH 7.24 (norm: 7.35 to 7.45), pCO2 4.5 kPa (norm: 4.5 to 6.0), pO2 2.9 kPa (norm: 10.6 to 13.3), base excess -12.1 mmol/L (norm: -2 to 2), O2 saturation 30% (norm: 94 to 99), glucose 1.3 mmol/L (norm: 3.5 The putative diagnosis was septic shock due to deep skin infection. Empirical antimicrobial treatment with ciprofloxacin, cefotaxime and selective digestive decontamination with polymyxin E, tobramycin and amphotericin B, was initiated, and the patient was resuscitated, started on vasopressors and admitted to the intensive care unit. Necrotising fasciitis was excluded upon surgical exploration. As VCNO non-O139 was isolated from blood and bullae content on admission day 3, antimicrobial treatment was switched to ciprofloxacin and cefotaxime. On the eighth admission day, the patient developed multi-organ failure (MOF). With the working diagnosis 'hospital acquired infection', gentamicin and flucloxacillin were added. The next day, blood cultures showed Candida albicans and before additional treatment was started the patient died from MOF and sepsis. At post-mortem examination C. albicans and Aspergillus fumigatus, but no Vibrio spp. were cultured from several organs including lungs, spleen, liver and intestine.
Microbiology findings
Within 24 hours from presentation at the ED blood cultures and cultures of bullae content grew rod-shaped/ curved Gram-negative bacteria which were oxidase-, katalase-and DNase-positive. MALDI-TOF analysis showed V. albensis with a score of 2.0 which corresponds with a secure identification on genus level and probable identification on species level (norm: 2.0 to 2.3). Additional biochemical testing (i.e. API 20E, Biomerieux) indicated V. cholerae. The microorganism did not agglutinate with O1-Ogawa or O1-Inaba antisera, was sensitive to the vibriostatic compound O/129 and was therefore labelled VCNO. This finding was confirmed and supplemented i.e. non-O 139, by the Dutch National Institute for Public Health and Environment (RIVM). In house susceptibility testing by disk diffusion showed ciprofloxacin and co-trimoxazole sensitivity.
Cultures of the tuna salad packaging did not reveal any Vibrio spp.
Case 2
A man in his late 60s with a medical history of heart disease, insulin-dependent diabetes mellitus type II, a cholecystectomy and an aneurysm of the abdominal aorta, presented to the ED with severe diarrhoea. Two weeks earlier, while on one of the Dutch islands, he suffered from severe diarrhoea for two days after having eaten raw herring. There was initial improvement, but the watery diarrhoea recurred and he consulted a general practitioner who referred him to hospital. There was no blood or mucus in his stool. He did not report any surface water contact.
Upon hospital admission, the patient was mildly icteric and had dyspnoea (respiratory rate 29/minute; norm: 12 to 18), lowered O2 saturation of 91% without supplemental oxygen. He was tachycardic (129/minute), blood pressure was slightly elevated (132/92 mmHg) and he had a temperature of 38 °C. Aside from abdominal distention, physical examination of the abdomen, heart, lungs and skin on the extremities showed no abnormalities. Ultrasound scan of the abdomen showed no abnormalities except steatosishepatis and liver cysts (4 cm in diameter). The electrocardiogram and abdominal X-ray were normal. The chest X-ray revealed signs of congestive heart failure.
Parameters of the arterial blood analysis were within normal range. Other laboratory findings at admission showed a mild leucocytosis of 14. (norm: 0 to 5), amylase 12 U/L (norm: 0 to 100), lipase 15 U/L (norm: 0 to 70) and lactate 2.3 mmol/L (norm: 0 to 1.8).
The diagnosis was sepsis and after obtaining blood cultures, treatment with amoxicillin-clavulanic acid and gentamicin was initiated according to the local sepsis treatment protocol. On the second admission day, the Gram-negative rod was isolated and suspected to be Salmonella spp. Treatment was switched to co-trimoxazole. Later that day, as the isolate tested oxidase-positive, the working diagnosis was changed to Pseudomonas spp. and treatment was switched to ciprofloxacin. Ciprofloxacin was continued after the identification of V. cholerae. The patient recovered fully, was discharged after five days with oral ciprofloxacin, and returned to his island holiday. 
Microbiology findings
Case 3
A man in his early 70s presented at the ED with general malaise, dizziness, decreased appetite, coughing and dyspnoea that had been lasting for one week. Relevant medical history comprised heart failure and a hepatojejunostomy for chronic cholangitis more than a decade before presentation. He had not been travelling or swimming, but habitually caught eel in the Ijsselmeer lake that summer and cleaned the eel himself. He did not report having consumed the eel or having had contact with lake water other than taking eel out of fishing nets, or of wounds or lacerations on his hands before his illness.
Upon hospital admission, he had a temperature of 39°C, heart rate of 66/minute, blood pressure of 110/70 mm/ Hg and oxygen saturation was normal without oxygen administration. He was disorientated and had trouble concentrating. There were no signs of gastroenteritis or abnormalities on chest examination. No apparent skin lesions were reported.
Arterial blood analysis showed a pH 7.46, The patient was initially empirically treated for sepsis with ceftriaxone and gentamicin, then switched to oral amoxicillin-clavulanic acid. He recovered completely and was discharged after seven days of hospitalisation. 
Microbiology findings
Review
The initial search yielded 163 unique articles and 155 duplicates (Figure 1 ). Reference checking resulted in identification of two additional unique articles. Of the 165 retrieved articles, 77 were excluded based on title or abstract, leaving 88 articles including 82 case reports and six articles reporting case series [90] [91] [92] [93] [94] [95] .
Case reports
The 82 articles retrieved covered 90 patients; 23 (26%) of them were female and the mean age was 49 (0-84) years. Cases were reported worldwide; 22 (25%) were identified in Europe, 19 (21%) in the United States of America, 30 (33%) in the Asian continent and 19 (21%) in the remaining continents. The remaining case characteristics are presented in Table 2 (extraction table for data available from authors upon request).
The most frequently reported symptom was gastroenteritis (51/90; 57%) followed by fever without gastroenteritis ( tested (intermediately) resistant), trimethoprim-sulfamethoxazole (4/37), ciprofloxacin (2/24), gentamicin (1/37) and doxycycline (3/38) . Antimicrobials to which V. cholerae non-O1 isolates appeared to be susceptible in vitro, without exception, were cephalotin (n=14 tested), cefuroxime (n=10), cefotaxime (n=14), ceftazidime (n=12), ceftriaxone (n=15), amikacin (n=17) and chloramphenicol (n=33). Toxin production of the isolates was not consistently reported in literature and therefore not included in the analysis.
Case series
Details of the six retrieved case series were extracted and analysed briefly given the selected nature of the sample (Table 2) . Altogether, 82 patients with VCNO bacteraemia were retrieved, the majority of reports originating from the Asian continent. As in the three case reports described above, most patients were male. In contrast, fever was the most frequent presenting symptom and risk factors could be identified in only a minority of patients (24/82; 29%).
Overall, the number of cases reported peaked in 1996, 1998, 2007 and 2011 ( Figure 2 ).
Discussion
We presented three cases of VCNO bacteraemia that were identified in the Netherlands between 2006 and 2013as well as 172 cases from literature occurring between 1980 and 2014. Corresponding with current knowledge, both the recently identified cases and the previously reported ones show that patients are typically male, often have a history of liver/bile duct disease and the presenting symptoms often include gastroenteritis, fever and bullae [1] . The suspected sources while seldom confirmed microbiologically, are commonly fish and surface water. In contrast to previous reports, however, we found that a great variety in clinical presentation does occur, ranging from lethargy to meningitis, endophthalmitis, cough and dyspnoea [1] . Severe outcomes include neurological impairment, lower limb amputation and death. All three Dutch cases presented during summer, the season of recreational activities such as fishing, swimming and of flourishing microorganisms in surface waters due to rising temperatures [96] [97] [98] .
A major strength of our analysis is that it provides a complete overview of what is known about VCNO bacteraemia, whereas other reports merely describe individual cases or a selection of case reports. The search was formulated by an experienced scientist (MFE) and an information specialist (JS) and articles were provided by the LUMC library which has access to over 9,000 leading (bio-)medical journals. Therefore, we consider that this review includes all relevant published articles published in Dutch and English and provides a complete overview of the available literature on VCNO bacteraemia.
The summary of data on antimicrobial susceptibility provided here may assist physicians in choosing an adequate treatment regimen. The data indicate that administration of a cephalosporin is likely to be the best option when dealing with VCNO bacteraemia. However, an important factor that hinders the extrapolation of our data to clinical practice is publication bias, many authors did not report susceptibility data. This is crucial when evaluating resistance data, as many authors solely reported the susceptibility to antimicrobials administered to the patient in question. Additional relevant data on antimicrobial resistance that may very well have been available to the authors was not published.
After searching current literature for the aetiology of VCNO bacteraemia, we could not reveal why males are affected more frequently than females, but found a similar trend in infections with other Vibrio spp [99] . The role of immunocompromising conditions in acquiring VCNO bacteraemia seems clear and the influence of liver cirrhosis can probably be attributed to high ferritin levels which are required for the metabolism of Vibrio spp [100] .
Aside from predisposing conditions and exposure, bacterial virulence may very well play a significant role in the pathogenesis of VCNO bacteraemia. VCNO toxins are being studied and several are known e.g. ctx; large excretion of fluids and electrolytes into the lumen hly-AET; hemolysin, rtxA; actin cross linking, hap; haemagglutinin protease, type 3 and 6 secretion system, nanH; neuraminidase, NAG-ST; heat-stable enterotoxin. The clinical significance of these toxins (e.g. their role in bulla formation, remains yet to be determined [101, 102] .
In conclusion, VCNO bacteraemia is a disease that can be fatal and poses a threat around the globe especially to patients with a history of alcohol abuse and/or liver cirrhosis. Physicians should be aware of the possibility of VCNO bacteraemia in patients presenting with gastroenteritis, fever or bullae after consumption of or contact with seafood or potentially contaminated water. However, risk factors often remain unidentified, the clinical presentation varies greatly and a quick microbiological diagnosis is indispensable. Cephalosporins are likely the best treatment option for VCNO bacteraemia.
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